CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,228 enrolled
Drug / intervention
Removal of Financial Barriers +2 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04798664
NCT04798664N/ACompleted
CompareCT.gov

Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening

Abramson Cancer Center at Penn Medicine·interventional·Posted Mar 15, 2021·Updated Feb 25, 2026

In Brief

A clinical study evaluating Removal of Financial Barriers, Financial Incentives, and 1 other intervention for Smoking Cessation. Completed, enrolled 3,228 participants across 5 sites.

Detailed Summary

To compare the effectiveness of four interventions to promote sustained, biochemically confirmed smoking abstinence for 6 months among underserved smokers referred for lung cancer screening at four large U.S. health systems.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking Cessation
CountriesUnited States
CollaboratorsPatient-Centered Outcomes Research Institute

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMar 15, 2021
Enrollment StartMay 17, 2021
Primary CompletionNov 4, 2024
Study CompletionApr 29, 2025
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 5.3 years ago

Interventions

Removal of Financial Barriersbehavioral

Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications

Financial Incentivesbehavioral

Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months.

Mobile Health Applicationbehavioral

Episodic future thinking tool to overcome temporal discounting of future